Objectives for the conference:
The objectives for this session are to identify key priorities for HOME over the next 5 years supporting the established COS. We would like to develop four working Groups (WG) corresponding to each domain in the clinical trials COS (Signs, Symptoms, QOL, and Eczema Control).
Enable,
support and encourage attendees to begin work on additional domains for the
HOME Clinical Practice Set (HOME-CP). We would like to continue to identify
instruments that are valid and feasible for measuring disease domains in the
clinical practice setting.
Target audience
HOME
is a global initiative of patients, healthcare professionals, journal editors,
regulatory authorities and the pharmaceutical industry, and welcomes anyone
interested in atopic eczema.
Harmonizing Outcome Measures for Eczema (HOME)
Saturday 25 September 13:00 – 16:00
Supporting Implementation of the Completed COS
Session 1: Plenary Talks
Chair: Christian Apfelbacher
13:00 – 13:10 Introduction to HOME IX
13:10 – 13:30 Looking Back
13:30 -14:00 Lecture: HOME at Present
14:00 -14:05 Break
Session 2: Small Group Breakout Sessions
Chair: Eric Simpson
14:05-15:05 Small Group Breakouts
15:05 – 15:15 Break
Session 3: Small Group Reports and Future Plans
Chair: Phyllis Spuls
15:15 – 15:50 Breakout Group Leader Reports and Group Feedback
15:50 – 16:00 Wrap Up: Eric Simpson and Christian Apfelbacher
Sunday 26 September 17:00 – 20:00
New Directions - Future of HOME
Chair: Kim Thomas
17:00 - 17:30 OMERACT/COMET Lecture:
17:30 – 17:45 Review of Day 1
Speaker: Kim Thomas
17:45 – 18:05 Break
18:00 – 18:30 Future of HOME: Addressing Implementation of the COS
18:30 – 19:15 Future of HOME: Additional Business
19:15 – 19:45 HOME Diplomacy
19:45 – 20:00 Wrap Up and Closing Statements
Tuesday 28 September 17:15 - 17:30
Contributing to feedback presentations from participating Groups
CS COUSIN and COMFA Joint Meeting
c/o The Conference Collective Ltd
8 Waldegrave Road
Teddington, Middlesex
TW11 8HT, UK
CS-Cousin@conferencecollective.co.uk
+44 (0) 20 8977 7997
This meeting is co-organised and partly funded by the COST Action COMFA CA18227, supported by COST (European Cooperation in Science and Technology)
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.